Nevro Corp (NASDAQ:NVRO) Director Michael F. Demane sold 139,514 shares of Nevro Corp stock in a transaction on Thursday, October 6th. The stock was sold at an average price of $97.46, for a total value of $13,597,034.44. Following the transaction, the director now owns 532,425 shares in the company, valued at approximately $51,890,140.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Shares of Nevro Corp (NASDAQ:NVRO) opened at 96.08 on Friday. The company’s 50 day moving average price is $97.76 and its 200-day moving average price is $78.28. The firm’s market capitalization is $2.74 billion. Nevro Corp has a 12 month low of $36.51 and a 12 month high of $106.93.
Nevro Corp (NASDAQ:NVRO) last posted its earnings results on Monday, August 8th. The company reported ($0.31) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.47) by $0.16. The firm earned $55.40 million during the quarter, compared to analyst estimates of $45.11 million. Nevro Corp’s revenue for the quarter was up 385.5% compared to the same quarter last year. On average, equities analysts predict that Nevro Corp will post ($1.42) earnings per share for the current fiscal year.
NVRO has been the topic of several analyst reports. Morgan Stanley reiterated a “buy” rating and set a $86.00 price target on shares of Nevro Corp in a report on Wednesday, June 29th. Wells Fargo & Co. initiated coverage on Nevro Corp in a report on Tuesday, July 12th. They set an “outperform” rating on the stock. Zacks Investment Research upgraded Nevro Corp from a “hold” rating to a “buy” rating and set a $110.00 price target on the stock in a report on Wednesday. William Blair initiated coverage on Nevro Corp in a report on Tuesday, July 19th. They set an “outperform” rating on the stock. Finally, JMP Securities lifted their price target on Nevro Corp from $90.00 to $110.00 and gave the stock a “market outperform” rating in a report on Tuesday, August 9th. Eleven analysts have rated the stock with a buy rating, Nevro Corp currently has a consensus rating of “Buy” and an average target price of $104.00.
Hedge funds have recently bought and sold shares of the stock. M&T Bank Corp raised its stake in Nevro Corp by 16.2% in the second quarter. M&T Bank Corp now owns 7,359 shares of the company’s stock valued at $543,000 after buying an additional 1,025 shares during the period. California Public Employees Retirement System raised its stake in Nevro Corp by 37.1% in the second quarter. California Public Employees Retirement System now owns 13,300 shares of the company’s stock valued at $981,000 after buying an additional 3,600 shares during the period. Emerald Acquisition Ltd. purchased a new stake in Nevro Corp during the second quarter valued at $6,949,000. Mariner Investment Group LLC purchased a new stake in Nevro Corp during the second quarter valued at $954,000. Finally, Swiss National Bank raised its stake in Nevro Corp by 32.2% in the second quarter. Swiss National Bank now owns 33,700 shares of the company’s stock valued at $2,486,000 after buying an additional 8,200 shares during the period.
Nevro Corp Company Profile